Minervax raises €47.4m in Series B funding round for GBS shotDenmark’s MinervaX has raised €47.4 million (around $56 million) in a Series B funding round to take its Share XMinervax raises €47.4m in Series B funding round for GBS shothttps://pharmaphorum.com/news/minervax-raises-e47-4m-in-series-b-funding-round-for-gbs-shot/
Swiss start-up Noema raises $59m to develop neurology drugs offloaded by RocheSwiss biotech Noema has raised 54 million Swiss francs ($59m) to develop four neurological disorder drugs licensed in Share XSwiss start-up Noema raises $59m to develop neurology drugs offloaded by Rochehttps://pharmaphorum.com/news/swiss-start-up-noema-raises-59m-to-develop-neurology-drugs-offloaded-by-roche/
Biotech trends in COVID era: the pharmaphorum podcastIn episode 26 the pharmaphorum podcast hears from David Solomon, a 30-year life sciences industry veteran who recently Share XBiotech trends in COVID era: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/biotech-trends-pharnext-david-solomon/
Online Live Team Pharma Forecasting Training Now AvailableWorking remotely can have its challenges, why not get together for a fun and rewarding learning experience and Share XOnline Live Team Pharma Forecasting Training Now Availablehttps://pharmaphorum.com/events/online-pharma-forecasting-training/
Catamaran joins the CAR-NK fleet, raising $42m in first roundCatamaran Bio has weighed anchor with a $42 million first-round financing that will be used to pull its Share XCatamaran joins the CAR-NK fleet, raising $42m in first roundhttps://pharmaphorum.com/news/catamaran-joins-the-car-nk-fleet-raising-42m-in-first-round/
VC firm SR One completes GSK spin-out, raising $500mTrans-Atlantic biotech venture capital firm SR One has completed its spin-out from GlaxoSmithKline and closed its first fund Share XVC firm SR One completes GSK spin-out, raising $500mhttps://pharmaphorum.com/news/vc-sr-one-completes-gsk-spin-out-raising-500m/
TGFB for Immuno-Oncology Drug Development SummitAre you interested in finding the next breakthrough in immuno-oncology preclinical or clinical development? Recent scientific, clinical breakthroughs Share XTGFB for Immuno-Oncology Drug Development Summithttps://pharmaphorum.com/events/tgfb-for-immuno-oncology-drug-development-summit/
New CEO Mortazavi takes UK biotech e-therapeutics into gene silencingUK biotech e-therapeutics has a new CEO, with executive chairman and former Silence Therapeutics chief Ali Mortazavi chosen Share XNew CEO Mortazavi takes UK biotech e-therapeutics into gene silencinghttps://pharmaphorum.com/news/new-ceo-mortazavi-takes-e-therapeutics-into-gene-silencing/
UK biotech sector sets new record with more than £1bn investment in Q3There has been a well-publicised boom in biotech investment during the pandemic, and the UK is no exception, Share XUK biotech sector sets new record with more than £1bn investment in Q3https://pharmaphorum.com/news/uk-biotech-sector-sets-new-record-with-more-than-1bn-investment-in-q3/
